EcoDrugPlus

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSTTRG00000015363
Gene Symbol: TUBB4B
1 Cross references
317 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSTTRG00000003703
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSTTRG00000008334
Gene Symbol: TUBB
1 Cross references
11 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSTTRG00000010250
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSTTRG00000015465
Gene Symbol: TH
1 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSTTRG00000009555
Gene Symbol: TYK2
1 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSTTRG00000008097
Gene Symbol: TIE1
1 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSTTRG00000010194
Gene Symbol: UTRN
1 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSTTRG00000008961
Gene Symbol: VEGFA
1 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSTTRG00000012578
Gene Symbol: VDR
1 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSTTRG00000015547
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSTTRG00000000168
Gene Symbol: XDH
1 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).